Genetic susceptibility to type 1 diabetes mellitus in humans

Physiological Research

Volumn 56, Issue 3, 2007, Pages 255-266

  Kantarova D ^a,b,d   Buc, M ^c  

^a Physics and Informatics   (Slovakia)

^b Martin Centre of Immunology   (Slovakia)

^c Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^d FACULTY HOSPITAL   (Slovakia)

Author keywords

CD25; CTLA4; HLA; IDDM; Insulin; PTPN22; Type 1 diabetes mellitus

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; HLA ANTIGEN; INSULIN; LEUKOCYTE ANTIGEN; PROTEIN TYROSINE PHOSPHATASE; TYROSINE PROTEIN PHOSPHATASE, NON RECEPTOR TYPE 22; TYROSINE PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 22; UNCLASSIFIED DRUG;

ENVIRONMENT; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; SHORT SURVEY;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; DIABETES MELLITUS, TYPE 1; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; INSULIN; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 34547285623     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (82)

1. ANJOS S, NGUYEN A, OUNISSI-BENKALHA H, TESSIER MC, POLYCHRONAKOS C: A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 277: 46478-46486, 2002.
2. ANJOS SM, TESSIER MC, POLYCHRONAKOS C: Association of the cytotoxic T lymphocyte-associated antigen 4 gene with Type 1 Diabetes: evidence for independent effects of two polymorphisms on the same haplotype block J Clin Endocrinol Metab 89: 6257-6265, 2004.
3. ATKINSON MA, BOWMAN MA, CAMPBELL L, DARROW BL, KAUFMAN DL, MACLAREN N: Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 94: 2125-2129, 1994.
4. BABU SR, CONANT GC, ELLER E, ROBERTS CM, GOWAN K, EISENBARTH GS, FAIN PR, VARDI P: A second-generation genome screen for linkage to type 1 diabetes in a Bedouin Arab family. Ann N Y Acad Sci 1037: 157-160, 2004.
5. BARRAT BJ, PAYNE F, LOWE CE, HERMANN R, HEALY BC, HAROLD D, CONCANNON P, GHARANI N, MCCARTHY MI, OLAVESEN MG: Remapping the insulin gene/IDDM2 locus in type 1 diabetes. Diabetes 53: 1884-1889, 2004.
6. BENNET ST, LUCASSEN AM, GOUGH SC, POWELL EE, UDLIEN DE, PRITCHARD LE, MERRIMN ME, KAWAGUCHI Y, DRONSFIELD MJ, POCIOT F: Susceptibility to human type diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 9: 284-292, 1995.
7. BERGHOLDT R, GHANDIL P, JOHANNESEN J, KRISTIANSEN OP, KOCKUM I, LUTHMAN H, RØNNINGEN KS, NERUP J, JULIER C, POCIOT F: Genetic and functional evaluation of an interleukin-12 polymorphism (IDDM18) in families with type 1 diabetes. J Med Genet 41: e39, 2004.
8. BOTTINI N, MUSUMECI L, ALONSO A, RAHMOUNI S, NIKA K, ROSTAMKHANI M, MACMURRAY J, MELONI GF, LUCARELLI P, PELLECCHIA M, EISENBARTH GS, COMINGS D, MUSTELIN T: A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36: 337-338, 2004.
9. BUC M: A review: The major histocompatibility complex in man. Folia Biol (Prague) 39: 223-242, 1993.
10. BUC M: Autoimmunity and Autoimmune Diseases (in Slovak). Veda, Bratislava, 2005, 492 pp.
11. BUC M, BUCOVÁ M, JAVOR J, KRIVOŠÍKOVÁ M, STUCHLÍKOVÁ M, SHAWKATOVÁ I., MICHALKOVÁ D, BARÁKL', JANČOVÁ E, PETŘEK M: Associations between HLA class II alleles and type 1 diabetes mellitus in the Slovak population. Endocr Regul 40: 1-6, 2006.
12. BUCOVÁ M: A role of cytokines in local and systemic inflammation, and septic shock. (in Slovak) Vnitr Lek 48: 755-762, 2002.
13. CAREL JC, BOITARD C, BOUGNERES PF: Decreased insulin response to glucose in islet cell antibody-negative siblings of type 1 diabetic children. J Clin Invest 92: 509-513, 1993.
14. ČERNÁ M, NOVOTA P, KOLOSTOVÁ K, Č EJKOVÁ P, ŽĎÁRSKÝ E, NOVÁKOVÁ D, KUČERA P, NOVÁK J, ANDĚL M: HLA in Czech adult patients with autoimmune diabetes mellitus: comparison with Czech children with type 1 diabetes and patients with type 2 diabetes. Eur J Immunogenet 30: 401-407, 2003.
15. CHOWDHURY TA, MIJOVIC CH, BARNETT AH: The aetiology of type I diabetes. Clin Baillieres Best Pract Res Clin Endocrinol Metabol 13: 181-195, 1999.
16. CONCANNON P, ERLICH HA, JULIER C, MORAHAN G, NERUP J, POCIOT F, TODD JA, RICH SS, The Type 1 Diabetes Genetics Consortium: Type 1 Diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes 54: 2995-3001, 2005.
17. COPEMAN JB, CUCCA F, HEARNE CM, CORNALL RJ, REED PW, RONNINGEN KS, UNDLIEN DE, NISTICO L, BUZZTTI R, TOSI R: Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet 9: 80-85, 1995.
18. COX NJ, WAPELHORST B, MORRISON VA, LINDSEY JOHNSON L, LESYA PINCHUK L, SPIELMAN RS, JOHN A. TODD JA, CONCANNON P: Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet 69: 820-830, 2001.
19. DAHLQUIST G: The aetiology of type 1 diabetes: an epidemiological perspective. Acta Paediatr Suppl 425: 5-10, 1998.
20. DAHLQUIST G, BLOM L, TUVEMO T, NYSTROM L, SANDSTROM A, WALL S: The Swedish childhood diabetes study-results from a nine-year case register and a one-year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders. Diabetologia 32: 2-6, 1989.
21. DAVIES JL, KAWAGUCHI Y, BENNETT ST, COPEMAN JB, CORDELL HJ, PRITCHARD LE, REED PW, GOUGH SC, JENKINS SC, PALMER SM: A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371: 130-136, 1994.
22. DELEPINE M, POCIOT F, HABITA C, HASHIMOTO L, FROGUEL P, ROTTER J, CAMBON-THOMSEN A, DESCHAMPS I, DJOULAH S, WEISSENBACH J, NERUP J, LATHROP M, JULIER C: Evidence of a non-MHC susceptibility locus in type I diabetes linked to HLA on chromosome 6. Am J Hum Genet 60: 174-187, 1997.
23. DRYKONINGEN CE, MULDER AL, VAANDRAGER GJ, LAPORTE RE, BRUINING GJ: The incidence of male childhood type 1 (insulin-dependent) diabetes mellitus is rising rapidly in the Netherlands. Diabetologia 35: 139-142, 1992.
24. ELLIOTT RB, HARRIS DP, HILL JP, BIBBY NJ, WASMUTH HE: Type I (insulin-dependent) diabetes mellitus and cow milk: casein variant consumption. Diabetologia 42: 292-296, 1999.
25. ESPOSITO L, HILL NJ, PRITCHARD LE, CUCCA F, MUXWORTHY C, MERRIMAN ME, WILSON A, JULIER C, DELEPINE M, TUOMILEHTO J, TUOMILEHTO-WOLF E, IONESCO-TIRGOVISTE C, NISTICO' L BUZZETTI R, POZZILLI P, FERRARI M, BOSI E, POCIOT F, NERUP J, BAIN SC, TODD JA: Genetic analysis of chromosome 2 in type 1 diabetes: analysis of putative loci IDDM7, IDDM12, and IDDM13 and candidate genes NRAMP1 and IA-2 and the interleukin-1 gene cluster. Diabetes. 47: 1797-1799, 1998.
26. FIELD LL, TOBIAS R, THOMSON G, PLON S: Susceptibility to insulin-dependent diabetes mellitus maps to a locus (IDDM11) on human chromosome 14q24.3-q31. Genomics 33: 1-8, 1996.
27. FIELD LL, LARSEN Z, POCIOT F, NERUP J, TOBIAS R, BONNEVIE-NIELSEN V: Evidence for a locus (IDDM16) in the immunoglobulin heavy chain region on chromosome 14q32.3 producing susceptibility to type 1 diabetes. Genes Immun 3: 338-344, 2002.
28. HILL RJ, ZOZULYA S, LU YL, WARD K, GISHIZKY M, JALLAL B: The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation. Exp Hematol 30: 237-244, 2002.
29. GARDNER SG, BINGLEY PJ, SAWTELL PA, WEEKS S, GALE EA: Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis. The Bart's-Oxford Study Group. BMJ 315: 713-717, 1997.
30. GOTTLIEB MS: Diabetes in offspring and siblings of juvenile- and maturity-onset-type diabetics. J Chronic Dis 33: 331-339, 1980.
31. GOTTLIEB PA, EISENBARTH GS: Human Autoimmune Diabetes. In: Molecular Pathology of Autoimmune Diseases. AN THEOFILOPOULOS, CA BONA (eds), Taylor & Francis, New York, 2002, pp 588-613.
32. + relatives with DQA1*0102/ DQB1*0602 have expected 0602 sequence and DR types. J Autoimmun 18: 67-70, 2002.
33. HEINO L, LÖNNROT M, KNIP P, KUPILA A, ERKKILA S, TOIVONEN A, VAHASALO P, ILONEN J, SIMELL O, HYOTY H: No evidence of abnormal regulation of antibody response to coxackievirus B4 antigen in prediabetic children. Clin Exp Immunol 126: 432-436. 2001.
34. HORWITZ MS, BRADLEY LM, HARBERTSON J, KRAHL T, LEE J, SARVETNICK N: Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 7: 781-785, 1998.
35. JONES EY, FUGGER L, STROMINGER JL, SIEBOLD CH: MHC class II proteins and disease: a structural perspective. Nat Rev Immunol 6: 271-282, 2006.
36. + Treg cells fit. Nat Immunol 6: 1071-1072, 2005.
37. KRÁLOVIČOVÁ J, GAUNT TR, RODRIGUEZ S, WOOD PJ, DAY IN, VOŘECHOVSKÝ I: Variants in the human insulin gene that affect pre-mRNA splicing: is -23HphI a functional single nucleotide polymorphism at IDDM2? Diabetes 55: 260-264, 2006.
38. KRISTIANSEN OP, LARSEN ZM, POCIOT F: CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity? Genes Immun 1: 170-184, 2000a.
39. KRISTIANSEN OP, POCIOT F, BENNETT EP, CLAUSEN H, JOHANNESEN J, NERUP J, MANDRUP-POULSEN T: IDDM7 links to insulin-dependent diabetes mellitus in Danish multiplex families but linkage is not explained by novel polymorphisms in the candidate gene GALNT3. Hum Mut 15: 295-296, 2000b.
40. KRISTIANSEN OP, KARLSEN AE, LARSEN ZM, JOHANNESEN J, POCIOT F, MANDRUP-POULSEN T: Identification of a type 1 diabetes-associated CD4 promoter haplotype with high constitutive activity. Scand J Immunol 59: 582-591, 2004.
41. KUKKO M, KIMPIMAKI T, KORHONEN S, KUPILA A, SIMELL S, VEIJOLA R, SIMELL T, ILONEN J, SIMELL O, KNIP M: Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigenconferred risk of type 1 diabets recruited from the general population. J Clin Endocrinol Metab 90: 2712-2717, 2005.
42. LAINE AP, NEJENTSEV S, VEIJOLA R, KORPINEN E, SJOROOS M, SIMELL O, KNIP M, AKERBLOM HK, ILONEN J: A linkage study of 12 IDDM susceptibility loci in the Finnish population. Diabetes Metab Res Rev 20: 144-149, 2004.
43. LAINE AP, TURPEINEN H, VEIJOLA R, HERMANN R, SIMELL O, KNIP M, ILONEN J: Evidence for linkage to and association with type 1 diabetes at the 3q21 region in the Finnish population. Genes Immun 7: 69-72, 2006.
44. LARSEN ZM, KRISTIANSEN OP, MATO E, JOHANNESEN J, PUIG-DOMINGO M, DE LEIVA A, NERUP J, POCIOT F: IDDM12 (CTLA4) on 2q33 and IDDM13 on 2q34 in genetic susceptibility to type 1 diabetes (insulin-dependent). Autoimmunity 31: 35-42, 1999.
45. LI H, LINDHOLM E, ALMGREN P, GUSTAFSSON Å, FORSBLOM C, LEIF GROOP L, TUOMI T: Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 diabetes. J Clin Endocrinol Metab 86: 574-582, 2001.
46. + T-cells from patients with type 1 diabetes. Diabetes 54: 92-99, 2005.
47. LUO DF, BUZZETTI R, ROTTER JI, MACLAREN NK, RAFFEL LJ, NISTICO L, GIOVANNINI C, POZZILLI P, THOMSON G, SHE JX: Confirmation of three susceptibility genes to insulin-dependent diabetes mellitus: IDDM4, IDDM5 and IDDM8. Hum Mol Genet 5: 693-698, 1996.
48. MAIER LM, WICKER LS: Genetic susceptibility to type 1 diabetes. Curr Opin Immunol 17: 601-608, 2005.
49. MARRON MP, RAFFEL LJ, GARCHON HJ, JACOB CO, SERRANO-RIOS M, MARTINEZ LARRAD MT, TENG WP, PARK Y, ZHANG ZX, GOLDSTEIN DR, TAO YW, BEAURAIN G, BACH JF, HUANG HS, LUO DF, ZEIDLER A, ROTTER JI, YANG MC, MODILEVSKY T, MACLAREN NK, SHE JX: Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 6: 1275-1282, 1997.
50. MARTINKA E, SHAWKATOVÁ I, STRAKOVÁ J, BUC M, MOKAN M: Latent autoimmune (type I) diabetes mellitus in adults. Part. II. Association of HLA antigens, status of cellular immunity and occurrence of other autoimmune diseases. (in Slovak) Vnitrni Lek 45: 103-109,1999.
51. MAURER M, LOSERTH S, KOLB-MAURER A, PONATH A, WIESE S, KRUSE N, RIECKMANN P: A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics 54: 1-8, 2002.
52. MEIN CA, ESPOSITO L, DUNN MG, JOHNSON GC, TIMMS AE, GOY JV, SMITH AN, SEBAG-MONTEFIORE L, MERRIMAN ME, WILSON AJ, PRITCHARD LE, CUCCA F, BARNETT AH, BAIN SC, TODD JA: A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet 19: 297-300, 1998.
53. MORAHAN G, HUANG D, YMER SI, CANCILLA MR, STEPHEN K, DABADGHA OP, WERTHER G, TAIT BD, HARRISON LC, COLMAN PG: Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet 27: 131-132, 2001.
54. MUNTONI S, FONTE MT, STODUTO S, MARIETTI G, BIZZARRI C, CRINO A, CIAMPALINI P, MULTARI G, SUPPA MA, MATTEOLI MC, LUCENTINI L, SEBASTIANI LM, VISALLI N, POZZILLI P, BOSCHERINI B, MUNTONI S: Incidence of insulin-dependent diabetes mellitus among Sardinian-heritage children born in Lazio region, Italy. Lancet 349: 160-162, 1997.
55. NAKAGAWA Y, KAWAGUCHI Y, TWELLS RC, MUXWORTHY C, HUNTER KM, WILSON A, MERRIMAN ME, COX RD, MERRIMAN T, CUCCA F, MCKINNEY PA, SHIELD JP, TUOMILEHTO J, TUOMILEHTO-WOLF E, IONESCO-TIRGOVISTE C, NISTICO L, BUZZETTI R, POZZILLI P., JONER G., THORSBY E., UNDLIEN DE, POCIOT F, NERUP J, RONNINGEN KS, BAIN SC, TODD JA: Fine mapping of the diabetes-susceptibility locus, IDDM4, on chromosome 11q13. Am J Hum Genet 63: 547-556, 1998.
56. NEPOM GT: HLA and type I diabetes. In: HLA in Health and Disease. R. LECHLER, A. WARRENS (eds), Academic Press, New York, 2000, pp 231-237.
57. NOBLE JA, VALDES AM, THOMSON G, ERLICH HA: The HLA class II locus DPB1 can influence susceptibility to type I diabetes. Diabetes 49: 121-125, 2000.
58. NOEL PJ, BOISE LH, THOMPSON CB: Regulation of T cell activation by CD28 and CTLA4. Adv Exp Med Biol 406: 209-217, 1996.
59. NORRIS JM, BEATY B, KLINGENSMITH G, YU LIPING, HOFFMAN M, CHASE HP, ERLICH HA, HAMMAN RF, EISENBARTH GS, REWERS M: Lack of association between early exposure to cow's milk protein and beta-cell autoimmunity. Diabetes Autoimmunity Study in the Young (DAISY). JAMA 276: 609-614.
60. ONKAMO P, VAANANEN S, KARVONEN M, TUOMILEHTO J: Worldwide increase in incidence of Type I diabetes - the analysis of the data on published incidence trends Diabetologia 42: 1395-1403,1999.
61. PAUST S, LU L, MCCARTY N, CANTOR H: Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci USA 101: 10398-10403, 2004.
62. POCIOT F, MCDERMOTT MF: Genetics of type 1 diabetes mellitus. Genes Immun 3: 235-249, 2002.
63. REDONDO MJ, REWERS M, YU L, GARG S, PILCHER CC, ELLIOTT RB, EISENBARTH GS: Genetic determination of islet cells autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type I diabetes: prospective twin study. BMJ 318: 698-702, 1999.
64. REDONDO MJ, KAWASAKI E, MULGREW CL, NOBLE JA, ERLICH HA, FREED BM, LIE BA, THORSBY E, EISENBARTH GS, UNDLIEN DE, RONNINGEN KS: DR- and DQ-associated protection from Type 1a diabetes: comparison of DRB1*1401 and DQA1*0102-DQB1*0602*. J Clin Endocrinol Metab 85: 3793-3797, 2000.
65. ROBLES DT, EISENBARTH GS.: Diabetes and related autoimmune diseases. In: Clinical Immunology. Principles and Praxis. RR RICH (ed), Mosby, St Louis, 2001, pp 82.1-82.18.
66. QUATRARO A, CONSOLI G, CERIELLO A, GIUGLIANO D: Heterogeneity of diabetes mellitus. Diabetologia 30: 678-679, 1987.
67. SALE MM, FITZGERALD LM, CHARLESWORTH JC, BOWDEN DW, RICH SS: Evidence for a novel type 1 diabetes susceptibility locus on chromosome 8. Diabetes 51 (Suppl 3): S316-S319, 2002.
68. SANJEEVI CB: HLA-DQ6-mediated protection in IDDM. Hum Immunol 61: 148-153, 2000.
69. SHAW MA, CLAYTON D, ATKINSON SE, WILLIAMS H, MILLER N, SIBTHORPE D. BLACKWELL JM: Linkage of rheumatoid arthritis to the candidate gene NRAMP1 on 2q35. J Med Genet 33: 672-677, 1996.
70. SMYTH D, COOPER JD, COLLINS JE, HEWARD JM, FRANKLYN JA, HOWSON JMM, VELLA A, NUTLAND S, RANCE HE, MAIER L, BARRATT BJ, GUJA C, IONESCU-TIRGOVISTE C, SAVAGE DA, DUNGER DB, WIDMER B, STRACHAN DP, RING SM, WALKER N, CLAYTON DG, TWELLS RCJ, GOUGH SCL, TODD JA: Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 Diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53: 3020-3023, 2004.
71. STASSI G, SCHLOOT N, PIETROPAOLO M: Islet cell autoantigen 69 kDa (ICA69) is preferentially expressed in the human islets of Langerhans than exocrine pancreas. Diabetologia 40: 120-121, 1997.
72. STUCHLÍKOVÁ M, VRLÍKOVÁ D, BARÁKL', BUC M: Association of HLA-DPB1 alleles with type I diabetes mellitus in the Slovak population. Bratislava Med J 107: 73-75, 2006.
73. TANG Q, ADAMS JY, TOOLEY AJ, BI M, FIFE BT, SERRA P, SANTAMARIA P, LOCKSLEY RM, KRUMMEL MF, BLUESTONE J: Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 7: 83-92, 2006.
74. UEDA H, HOWSON JM, ESPOSITO L et al: Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 506-511, 2003.
75. VALDES AM, NOBLE JA, GENIN E, CLERGET-DARPOUX F, ERLICH HA, THOMSON G: Modeling of HLA class II susceptibility to type I diabetes reveals an effect associated with DPB1. Genet Epidemiol 21: 212-223, 2001.
76. VELLA A, COOPER JD, LOWE CE, WALKER N, NUTLAND S, WIDMER B, JONES R, RING SM, MCARDLE W, PEMBREY ME, STRACHAN DP, DUNGER DB, TWELLS RC, CLAYTON DG, TODD JA: Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 76: 773-779, 2005.
77. VENAZI ES, BENOIST CH, MATHIS D: Good riddance: thymocyte clonal deletion prevents autoimmunity. Curr Opin Immunol 16: 197-202, 2004.
78. VILLASENOR J, BENOIST C, MATHIS D: AIRE and APECED: molecular insights into an autoimmune disease. Immunol Rev 204: 156-164, 2005.
79. WAGENER DK, SACKS JM, LAPORTE RE, MACGREGOR JM: The Pittsburgh study of insulin-dependent diabetes mellitus. Risk for diabetes among relatives of IDDM. Diabetes 31: 136-144, 1982.
80. YOON JW, AUSTIN M, ONODERA T: Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 30: 1173-1179, 1979.
81. ŽALKOVIČOVÁ M, BUC M, NIKS M, Š TEFANOVIČ J: Genetic determination of phagocytic activity of polymorphonuclear leucocytes Folia Biol (Prague) 34: 240-247. 1988.
82. ZAMANI M, POCIOT F, RAEYMAEKERS P, NERUP J, CASSIMAN JJ: Linkage of type I diabetes to 15q26 (IDDM3) in the Danish population. Hum Genet 98: 491-496, 1996.